Two U.S. Representatives have introduced a bill that would require Medicare to pay for off-label uses of all Part D drugs--as long as those uses are medically necessary and supported by published study data or standard medical practice. Report
Two U.S. Representatives have introduced a bill that would require Medicare to pay for off-label uses of all Part D drugs--as long as those uses are medically necessary and supported by published study data or standard medical practice. Report